In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

WuXi PharmaTech completes $156mm IPO on NYSE

Executive Summary

Chinese CRO WuXi PharmaTech has netted $155.9mm in its IPO on the NYSE by selling about 12mm American Depository Shares--including the overallotment--at $14 apiece (above its proposed $11-13 range); selling shareholders issued an additional 3.2mm ADSs.
Deal Industry
  • Biotechnology
  • Contract Research, Toxicology Testing-CRO
  • Pharmaceuticals
  • Services
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies

UsernamePublicRestriction

Register